MALTHOUSE SURGERY
THE CHARTER, ABINGDONCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 558 | 674 | 82.8% | |
CKD 4 | 2008 | 782 | 883 | 88.6% | |
CKD 5 | 2009 | 77 | 79 | 97.5% | |
CKD 5 | 2010 | 64 | 67 | 95.5% | |
CKD 5 | 2011 | 66 | 74 | 89.2% | |
CKD 5 | 2012 | 59 | 67 | 88.1% | |
CKD 5 | 2013 | 60 | 66 | 90.9% | |
CKD003 | 2014 | 66 | 69 | 95.7% | |
CKD003 | 2015 | 53 | 58 | 91.4% | |
NM84 | 2016 | 52 | 64 | 81.2% | |
NM84 | 2017 | 45 | 62 | 72.6% | |
NM84 | 2018 | 42 | 61 | 68.9% | |
NM84 | 2019 | 11 | 15 | 73.3% | |
NM84 | 2020 | 11 | 14 | 78.6% | |
NM84 | 2022 | 20 | 24 | 83.3% |